These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
449 related articles for article (PubMed ID: 29034584)
21. Sphingolipids in ocular inflammation. Chan AY; Mann SN; Chen H; Stone DU; Carr DJ; Mandal NA Adv Exp Med Biol; 2014; 801():623-9. PubMed ID: 24664751 [TBL] [Abstract][Full Text] [Related]
22. Immunoregulatory role of ocular macrophages: the macrophages produce RANTES to suppress experimental autoimmune uveitis. Sonoda KH; Sasa Y; Qiao H; Tsutsumi C; Hisatomi T; Komiyama S; Kubota T; Sakamoto T; Kawano Y; Ishibashi T J Immunol; 2003 Sep; 171(5):2652-9. PubMed ID: 12928419 [TBL] [Abstract][Full Text] [Related]
23. Controlled release of corticosteroid with biodegradable nanoparticles for treating experimental autoimmune uveitis. Luo L; Yang J; Oh Y; Hartsock MJ; Xia S; Kim YC; Ding Z; Meng T; Eberhart CG; Ensign LM; Thorne JE; Stark WJ; Duh EJ; Xu Q; Hanes J J Control Release; 2019 Feb; 296():68-80. PubMed ID: 30660629 [TBL] [Abstract][Full Text] [Related]
24. Complement, innate immunity and ocular disease. Sohn JH; Bora PS; Jha P; Tezel TH; Kaplan HJ; Bora NS Chem Immunol Allergy; 2007; 92():105-114. PubMed ID: 17264487 [TBL] [Abstract][Full Text] [Related]
25. Neuroinflammation in Retinitis Pigmentosa, Diabetic Retinopathy, and Age-Related Macular Degeneration: A Minireview. Massengill MT; Ahmed CM; Lewin AS; Ildefonso CJ Adv Exp Med Biol; 2018; 1074():185-191. PubMed ID: 29721943 [TBL] [Abstract][Full Text] [Related]
26. Gene delivery of a viral anti-inflammatory protein to combat ocular inflammation. Ildefonso CJ; Jaime H; Rahman MM; Li Q; Boye SE; Hauswirth WW; Lucas AR; McFadden G; Lewin AS Hum Gene Ther; 2015 Jan; 26(1):59-68. PubMed ID: 25420215 [TBL] [Abstract][Full Text] [Related]
27. Molecular pathology of macrophages and interleukin-17 in age-related macular degeneration. Chan CC; Ardeljan D Adv Exp Med Biol; 2014; 801():193-8. PubMed ID: 24664698 [TBL] [Abstract][Full Text] [Related]
31. A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration. Handa JT; Bowes Rickman C; Dick AD; Gorin MB; Miller JW; Toth CA; Ueffing M; Zarbin M; Farrer LA Nat Commun; 2019 Jul; 10(1):3347. PubMed ID: 31350409 [TBL] [Abstract][Full Text] [Related]
32. Anti-tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non-infectious uveitis. Barry RJ; Tallouzi MO; Bucknall N; Mathers JM; Murray PI; Calvert MJ; Moore DJ; Denniston AK Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012577. PubMed ID: 30562409 [TBL] [Abstract][Full Text] [Related]
33. Ocular immune privilege in the year 2010: ocular immune privilege and uveitis. Taylor AW; Kaplan HJ Ocul Immunol Inflamm; 2010 Dec; 18(6):488-92. PubMed ID: 21091058 [TBL] [Abstract][Full Text] [Related]
34. Modulating of ocular inflammation with macrophage migration inhibitory factor is associated with notch signalling in experimental autoimmune uveitis. Yang H; Zheng S; Mao Y; Chen Z; Zheng C; Li H; Sumners C; Li Q; Yang P; Lei B Clin Exp Immunol; 2016 Feb; 183(2):280-93. PubMed ID: 26400205 [TBL] [Abstract][Full Text] [Related]
35. A systematic review of biologics for the treatment of noninfectious uveitis. Takeuchi M Immunotherapy; 2013 Jan; 5(1):91-102. PubMed ID: 23256801 [TBL] [Abstract][Full Text] [Related]
36. Road to fulfilment: taming the immune response to restore vision. Dick AD Ophthalmic Res; 2012; 48(1):43-9. PubMed ID: 22398563 [TBL] [Abstract][Full Text] [Related]
37. Autoimmune and autoinflammatory mechanisms in uveitis. Lee RW; Nicholson LB; Sen HN; Chan CC; Wei L; Nussenblatt RB; Dick AD Semin Immunopathol; 2014 Sep; 36(5):581-94. PubMed ID: 24858699 [TBL] [Abstract][Full Text] [Related]